Baerbel Rohrer

Company: MitoChem Therapeutics

Job title: Chief Executive Officer

Seminars:

Preserving Sight in Patients With Neurodegenerative Diseases Through a First-in-Class Target 3:15 pm

Highlighting the implications of mitochondrial dysfunction underlying the pathological basis for tissue damage in retinal diseases Building a library of mitochondrial protective compounds to design a new class of small molecules that can treat neurodegeneration through the protection of mitochondrial homeostasisRead more

day: CONFERENCE DAY ONE